We have previously shown in vitro that recombinant Wnt-5a and a Wnt-5a-derived peptide impaired migration and invasion of ER-negative breast cancer cells [16], but had no effects on tumor cells proliferation or survival [17]. Here, WNT5A is linked to neoplasm.